prod.liab.rep. (Cch) P 13,882 James P. Conde Rhonda L. Conde James R. Conde Autumn Conde and Kimberly Conde v. Velsicol Chemical Corporation

24 F.3d 809, 1994 U.S. App. LEXIS 10752, 1994 WL 184966
CourtCourt of Appeals for the Sixth Circuit
DecidedMay 16, 1994
Docket93-3092
StatusPublished
Cited by58 cases

This text of 24 F.3d 809 (prod.liab.rep. (Cch) P 13,882 James P. Conde Rhonda L. Conde James R. Conde Autumn Conde and Kimberly Conde v. Velsicol Chemical Corporation) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
prod.liab.rep. (Cch) P 13,882 James P. Conde Rhonda L. Conde James R. Conde Autumn Conde and Kimberly Conde v. Velsicol Chemical Corporation, 24 F.3d 809, 1994 U.S. App. LEXIS 10752, 1994 WL 184966 (6th Cir. 1994).

Opinion

BOYCE F. MARTIN, JR., Circuit Judge.

Dr. James Conde, his wife Rhonda, and their three children appeal the district court’s grant of summary judgment for Velsi-col Chemical Corporation in this diversity products liability action. The Condes allege that Gold Crest C-100, Velsieol’s commercial termiticide, is a defective product that caused health problems and a loss of property value after it was applied to the basement area of the Condes’ home. The district court found that most of the expert testimony offered by the Condes with respect to the issue of medical causation was inadmissible, and further found that, even if it were admissible, the testimony was insufficient to allow a jury to conclude by a preponderance of the evidence that the Condes suffered personal injuries as a result of their exposure to chlordane. For the following reasons, we affirm.

I

In the first of its two opinions in this case, the district court stated the facts and relevant expert testimony in detail. Conde v. Velsicol Chemical Corp., 804 F.Supp. 972 (S.D. Ohio 1992). We summarize, therefore, only those facts necessary for an understanding of this appeal. On April 8, 1983, Swat Exterminating Company applied Velsieol’s Gold Crest C-100 termiticide to the basement area of the Condes’ house under construction in Pomeroy, Ohio. During the application, Swat poured four hundred gallons of Gold Crest C-100 into holes drilled in the house’s concrete foundation and soil perimeter. The foundation was water-saturated, and Swat did not plug the drill holes after filling them with the termiticide. By applying the termiticide in this manner, Swat violated federal criminal statutes relating to termiticide application, in addition to the express application instructions included in the termiticide’s federally-approved label.

The primary active ingredient of Gold Crest C-100 is a chlorinated cyclodiene commonly referred to as chlordane. If ingested in very high doses by human beings, chlordane is a deadly toxin that affects the central nervous system. Soon after the application of chlordane to their house, all of the members of the Conde family began experiencing numerous physical problems, including headaches, nausea, diarrhea, and abdominal pain. The family cat died unexpectedly in August 1986, and subsequent tests revealed chlordane in the cat’s liver. In November 1986, the Condes moved out of their house, and their acute symptoms subsided soon thereafter. Due to the chlordane contamination, and after a request by the Condes, the Meigs County, Ohio Board of Revision reassessed the value of the Conde home at zero.

Chemical analysis of air samples taken from the Conde home in 1984,1987, and 1991 showed chlordane concentrations averaging less than one microgram per cubic meter of air. The permissible exposure level set by the Occupational Safety and Health Administration in 1982 for workers engaged in the manufacture of chlordane was five hundred micrograms per cubic meter of air, assuming an exposure of eight hours per day, and fifty *811 weeks per year. Nineteen epidemiological studies have shown no apparent ill effects in human beings exposed to this latter level of chlordane. No studies of long-term exposure to very low levels of chlordane have been conducted. Numerous tests performed on blood and tissue samples obtained from the Condes revealed no detectable chlordane, transnonachlor, or other chlordane metabolites.

On April 8, 1985, the Condes brought this diversity action in the United States District Court for the Southern District of Ohio against Velsicol and Swat Exterminating Company. After settling with Swat and amending their complaint, the Condes sought damages for personal injuries and property damage resulting from Velsicol’s marketing of a defective and dangerous product. They also sought punitive damages from Velsicol for manufacturing a known defective product and for failing to report adverse chlordane testing results.

On October 13,1992, the district court, in a comprehensive opinion, granted summary judgment for Velsicol on the issues of medical causation and product defect. Id. With respect to the medical causation issue, the court found that the testimony of three of the Condes’ experts, Drs. McConnaehie, Zahal-sky, and Simon, was inadmissible under Federal Rules of Evidence 702 and 703, and further found that even if their testimony were admissible, it was insufficient to allow a jury to find, by a preponderance of the evidence, that Velsicol’s chlordane termiticide caused the Condes’ health problems. The court based its conclusion primarily on the following facts: (1) the methods used by the Condes’ experts, including “immune system panels,” are experimental (i.e. not generally accepted by others in the fields of toxicology and immunology), and the panels were conducted in a manner not conforming to generally accepted scientific protocols; (2) the experts were unable to connect in vitro tests, animal studies, and acute poisoning ease evidence with the Condes’ low levels of exposure and health problems; (3) none of the experts were able to point to peer-reviewed, scientific literature or studies supporting their theories of medical causation; (4) blood and tissue tests of the Condes did not reveal any chlordane or chlordane metabolites; and (5) the nineteen epidemiological studies had found no adverse health effects from chlordane doses hundreds of times higher than those to which the Condes were exposed.

On the issue of product defect, the district court applied the two-prong consumer expectation/risk-benefit analysis required by Ohio law under Knitz v. Minster Machine Co., 69 Ohio St.2d 460, 432 N.E.2d 814, cert. denied, 459 U.S. 857, 103 S.Ct. 127, 74 L.Ed.2d 110 (1982). The court found that, although the Condes initially had made out a claim on a consumer expectation theory, the risk-benefit analyses conducted by the Environmental Protection Agency both pre- and post-1983 did not establish that the risks of the product outweighed its benefits. Also, the court noted that the Condes did not adduce evidence showing that feasible, safer alternative products or formulations were available in the spring of 1983. The court thus granted summary judgment on both prongs of the test, stating with respect to consumer expectation that the Condes’ failure to prove medical causation was fatal to that claim.

On December 28, 1992, the district court, in a second opinion, granted summary judgment for Velsicol on the Condes’ remaining claims for property damage, psychological injury, and punitive damages. Conde v. Velsicol Chemical Corp., 816 F.Supp. 453 (S.D. Ohio 1992). The court found that an award for property damage was inappropriate because the Condes did not show that Gold Crest C-100 was a defective product, and that even if they had shown it to be defective, the Condes did not demonstrate that the termiticide was the cause in fact of any property damage. See R.H. Macy & Co. v. Otis Elevator Co., 51 Ohio St.3d 108, 554 N.E.2d 1313, 1316-17 (1990) (plaintiffs must establish causation in fact in a strict liability case).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
24 F.3d 809, 1994 U.S. App. LEXIS 10752, 1994 WL 184966, Counsel Stack Legal Research, https://law.counselstack.com/opinion/prodliabrep-cch-p-13882-james-p-conde-rhonda-l-conde-james-r-conde-ca6-1994.